GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Other Stockholders Equity

AdAlta (ASX:1AD) Other Stockholders Equity : A$-0.00 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Other Stockholders Equity?

AdAlta's Other Stockholders Equity for the quarter that ended in Dec. 2024 was A$-0.00 Mil.

AdAlta's quarterly Other Stockholders Equity declined from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil) and declined from Jun. 2024 (A$0.00 Mil) to Dec. 2024 (A$-0.00 Mil).

AdAlta's annual Other Stockholders Equity declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil) and declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil).

AdAlta Other Stockholders Equity Historical Data

The historical data trend for AdAlta's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Other Stockholders Equity Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AdAlta Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

AdAlta Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AdAlta's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AdAlta Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Other Stockholders Equity
Comparable Companies
ASX:IXC ASX:NSB ASX:ZLD ASX:CMB ASX:PAB ASX:VBS ASX:BGT ASX:BIT ASX:1AI ASX:CHM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Science Drive, La Trobe Institute for Molecular Science, Room 204, LIMS2, La Trobe University, Bundoora, VIC, AUS, 3086
Website
https://www.adalta.com.au
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

AdAlta Headlines

No Headlines